This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Summary of the case studies highlighted in this review and organized according to the adopted nanobiosensor transduction strategy.
Summary of the case studies highlighted in this review and organized according to adopted nanomaterial.
MIP versus antibody performance. The first three columns demonstrate typical LOD decreases when antibodies are replaced with MIPs. The last four columns demonstrate robust MIP potential for regeneration, which is not possible when fragile antibodies are used.
Alphabetized list of acronyms used in this review.